Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SH) has released its 2026 third quarter report.

For the first three quarters, the company recorded operating revenue of 1.623 billion yuan, representing a year-on-year increase of 8.29%.

The company reported a net loss attributable to shareholders of 231 million yuan, while the net loss after deducting non-recurring gains and losses stood at 286 million yuan. Basic earnings per share came in at -0.18 yuan.